tiprankstipranks
Protara Therapeutics completes first cohort in Phase 2 trial of TARA-002
PremiumThe FlyProtara Therapeutics completes first cohort in Phase 2 trial of TARA-002
2M ago
Protara Therapeutics announce results from THRIVE-1 study
Premium
The Fly
Protara Therapeutics announce results from THRIVE-1 study
2M ago
Protara Therapeutics price target lowered to $25 from $30 at Oppenheimer
Premium
The Fly
Protara Therapeutics price target lowered to $25 from $30 at Oppenheimer
3M ago
These 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
PremiumStock Analysis & IdeasThese 2 ‘Strong Buy’ Penny Stocks Could Surge Over 400%, Says Oppenheimer
7M ago
Protara Therapeutics files to sell 21.69M shares of common stock for holders
Premium
The Fly
Protara Therapeutics files to sell 21.69M shares of common stock for holders
7M ago
Protara Therapeutics reports Q1 EPS (97c), consensus (92c)
Premium
The Fly
Protara Therapeutics reports Q1 EPS (97c), consensus (92c)
7M ago
Protara announces alignment with FDA on path forward for IV Choline Chloride
PremiumThe FlyProtara announces alignment with FDA on path forward for IV Choline Chloride
8M ago
Protara Therapeutics CMO Resigns, Interim Successor Named
Premium
Company Announcements
Protara Therapeutics CMO Resigns, Interim Successor Named
8M ago
Protara Therapeutics expects cash to fud operations into 2Q25
Premium
The Fly
Protara Therapeutics expects cash to fud operations into 2Q25
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100